BACKGROUND: An estimated seven million Filipinos (10-12% of the population) are chronically infected with hepatitis B virus (HBV). Achieving high birth dose coverage with hepatitis B vaccine is critical for achieving the World Health Organization's Western Pacific Regional goal of reducing the prevalence of chronic HBV among children 5 years of age to <2% by 2012. METHODS: Seven months after the Philippines adopted a hepatitis B vaccine birth dose policy, hospitals with the highest number of deliveries were invited to participate in an assessment of implementation of the birth dose policy. Additionally, in metro Manila birth dose coverage was estimated before and after conducting a training workshop and supervisory follow-up for practitioners conducting home deliveries or deliveries at lying-in clinics. RESULTS: Of the country's largest 150 hospitals in terms of authorized bed capacity, 85 (56%) were included in this assessment. These hospitals had 55,719 deliveries during July-September 2007. Of these, 54% infants had a documented birth dose; however, only 22% were vaccinated within 24h of delivery. Having a copy of the hepatitis B vaccine vaccination policy (prevalence odds ratio [pOR]=4.7, 95% confidence interval [CI]=1.2-18.0), having standing orders pOR=4.8, 95% CI=1.3-18.1 and providing training pOR=18.9, 95% CI=5.3-67.0 were associated with >50% birth dose coverage in a hospital. In metro-Manila, regardless of place of birth, the training workshop and supervisory follow-up significantly improved hepatitis B vaccine administration within 24h after birth, increasing from 19% before to 74% after the training workshop and follow-up. CONCLUSIONS: Experience in the Philippines showed that actions by national, regional and health facility policy makers such as establishing national policies, distributing detailed and specific guidelines, conducting effective training and supervision, and having hospital standing orders substantially increased hepatitis B vaccine birth dose coverage. Copyright Â
BACKGROUND: An estimated seven million Filipinos (10-12% of the population) are chronically infected with hepatitis B virus (HBV). Achieving high birth dose coverage with hepatitis B vaccine is critical for achieving the World Health Organization's Western Pacific Regional goal of reducing the prevalence of chronic HBV among children 5 years of age to <2% by 2012. METHODS: Seven months after the Philippines adopted a hepatitis B vaccine birth dose policy, hospitals with the highest number of deliveries were invited to participate in an assessment of implementation of the birth dose policy. Additionally, in metro Manila birth dose coverage was estimated before and after conducting a training workshop and supervisory follow-up for practitioners conducting home deliveries or deliveries at lying-in clinics. RESULTS: Of the country's largest 150 hospitals in terms of authorized bed capacity, 85 (56%) were included in this assessment. These hospitals had 55,719 deliveries during July-September 2007. Of these, 54% infants had a documented birth dose; however, only 22% were vaccinated within 24h of delivery. Having a copy of the hepatitis B vaccine vaccination policy (prevalence odds ratio [pOR]=4.7, 95% confidence interval [CI]=1.2-18.0), having standing orders pOR=4.8, 95% CI=1.3-18.1 and providing training pOR=18.9, 95% CI=5.3-67.0 were associated with >50% birth dose coverage in a hospital. In metro-Manila, regardless of place of birth, the training workshop and supervisory follow-up significantly improved hepatitis B vaccine administration within 24h after birth, increasing from 19% before to 74% after the training workshop and follow-up. CONCLUSIONS: Experience in the Philippines showed that actions by national, regional and health facility policy makers such as establishing national policies, distributing detailed and specific guidelines, conducting effective training and supervision, and having hospital standing orders substantially increased hepatitis B vaccine birth dose coverage. Copyright Â
Authors: Michael O Baclig; May R Alvarez; Xerxes Morgan R Lozada; Cynthia A Mapua; Jingky P Lozano-Kühne; Mark Pierre S Dimamay; Filipinas F Natividad; Juliet Gopez-Cervantes; Ronald R Matias Journal: Int J Mol Epidemiol Genet Date: 2012-05-15
Authors: Lana Childs; Paul Adrien; Anna A Minta; Jeannot François; Nadia Phaïmyr Jn Charles; Valery Blot; Gloria Rey-Benito; Jodi L Vanden Eng; Rania A Tohme Journal: Am J Trop Med Hyg Date: 2019-07 Impact factor: 2.345
Authors: Peter Francis Raguindin; Merrylle Morales-Dizon; Josephine Aldaba; Lailani P Mangulabnan; Renelyn P Reyes; Nyambat Batmunkh; Maria Joyce Ducusin; Anna Lena Lopez Journal: J Public Health Policy Date: 2021-01-04 Impact factor: 3.526
Authors: Howard L Sobel; Maria Asuncion A Silvestre; Jacinto Blas V Mantaring; Yolanda E Oliveros; Soe Nyunt-U Journal: Acta Paediatr Date: 2011-03-07 Impact factor: 2.299
Authors: Luz Angela Choconta-Piraquive; Fernando De la Hoz-Restrepo; Carlos Arturo Sarmiento-Limas Journal: BMC Health Serv Res Date: 2016-07-21 Impact factor: 2.655